Top Institutions in Ophthalmology
Leading academic medical centers with strong ophthalmology and endocrinology research programs, especially those with dedicated retina specialists and translational research in diabetic eye disease and neurodegenerative ocular conditions, are at the forefront of investigating GLP-1RA effects on the retina.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with strong collaborations in diabetes-related eye disease and neuro-ophthalmology, enabling pioneering studies on GLP-1RA effects in retinal disorders.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a robust focus on diabetic eye disease and innovative retinal therapeutics, including early adoption of novel pharmacologic agents like GLP-1RAs.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a long-standing reputation for cutting-edge research in retinal diseases and neuro-ophthalmology, with active investigations into metabolic and neuroprotective mechanisms relevant to GLP-1RA therapies.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF combines strong ophthalmology and endocrinology departments, facilitating interdisciplinary research on diabetes and retinal diseases, including the role of GLP-1 receptor agonists in ocular pathophysiology.
